Clinical trial
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement: the UTAD Study of the Italian National Association of Breast Surgeons (ANISC)
NCT07278726 is registered in ClinicalTrials.gov with European Institute of Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement: the UTAD Study of the Italian National Association of Breast Surgeons (ANISC)
- Lead sponsor
- European Institute of Oncology
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 28, 2026
- Completion date
- November 30, 2033
- Enrollment
- 150 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
alnd, sentinel lymph node biopsy (slnb), targeted axillary dissection (tad)